scispace - formally typeset
T

Thomas S. Vedvick

Researcher at Salk Institute for Biological Studies

Publications -  11
Citations -  1508

Thomas S. Vedvick is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Pichia pastoris & Gene. The author has an hindex of 6, co-authored 11 publications receiving 1483 citations.

Papers
More filters
Journal ArticleDOI

Recent advances in the expression of foreign genes in Pichia pastoris

TL;DR: The Pichia pastoris heterologous gene expression system has been utilized to produce attractive levels of a variety of intracellular and extracellular proteins of interest and improvements in understanding and application have improved its utility even further.
Journal ArticleDOI

Primary structure of the γ subunit of the DHP-sensitive calcium channel from skeletal muscle.

TL;DR: Affinity-purified, polyclonal antibodies to the gamma subunit of the dihydropyridine (DHP)-sensitive, voltage-dependent calcium channel have been used to isolate complementary DNAs to the rabbit skeletal muscle protein from an expression library, and the deduced primary structure indicates that it is a glycosylated hydrophobic protein.
Journal ArticleDOI

High-level secretion of biologically active aprotinin from the yeast Pichia pastoris.

TL;DR: A synthetic gene encoding aprotinin (bovine pancreatic trypsin, inhibitor) was fused to the Saccharomyces cerevisiae prepro alpha mating factor leader sequence at the dibasic amino acid processing site, leading to the secretion of a biologically active aProtinin containing only a Glu-Ala N-terminal extension.
Journal ArticleDOI

High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid β-protein precursor

TL;DR: The use of the methylotrophic industrial yeast Pichia pastoris as a host system for the large scale production of the KPI domain of PN-2AβPP, a secreted isoform of the Alzheimer's amyloid β-protein precursor that contains the Kunitz-type protease inhibitor (KPI) domain, is described.
Journal ArticleDOI

Gene expression in yeast: Pichia pastoris.

TL;DR: Improvements in strains have boosted the yield of proteins and peptides to the commercially feasible range and the Pichia pastoris expression system will soon be used to manufacture proteins for human clinical trials.